CardioComm Solutions, Inc., established in 1989 and based in Toronto, Canada, specializes in developing advanced technological solutions for cardiac monitoring. The company delivers both sophisticated software and hardware products, as well as core laboratory reading services, specifically designed for electrocardiogram (ECG) and ambulatory arrhythmia detection systems. These comprehensive offerings cater to both the medical sector and individual consumers across the globe. At the heart of CardioComm's operations is proprietary technology that underpins the entire ECG workflow: from initial recording and seamless transmission to detailed viewing, in-depth analysis, comprehensive reporting, and secure long-term storage. This end-to-end capability is crucial for the effective screening, accurate diagnosis, and ongoing management of cardiac patients. Their unique device connectivity and ECG management platforms are integrated into diverse solutions, spanning general medical applications, consumer-grade health products, clinical research initiatives, and modern telemedicine services. The company's extensive software suite includes the Global ECG Management System (GEMS) for cardiac event monitoring, GlobalCardio 12 Lead—a web-enabled and EMR-compatible ECG device—and GEMS Lite for Windows, an electronic system for receiving ECG data. Complementary software modules further enhance their offerings, such as GEMS WIN Air for live wireless ECG monitoring, AutoAttendant to empower healthcare providers by automating routine tasks, and the GEMS HL7 Interface, which ensures compliant data exchange with other EMR systems. Additionally, GlobalCardio EMR integration facilitates the bi-directional transfer of crucial information, including patient data, reports, and related links. Beyond software, CardioComm provides a range of hardware products. These include the portable HeartCheck PEN and HeartCheck handheld ECG monitors, various Sirona telephonic and wireless event recorders, and the HeartCheck CardiBeat device. Furthermore, the company offers Application Service Provider (ASP) solutions, notably C4 ECG management services and HeartCheck SMART Monitoring. Their broader product portfolio also features GlobalCardio 3 Lead, the ECG Viewer SDK, QRS Diagnostic, and QRS 12 Lead Universal.
The current price of EKGGF is $0.01 USD — it has decreased by -8.26% in the past 24 hours. Watch CardioComm Solutions stock price performance more closely on the chart.
What is CardioComm Solutions stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange CardioComm Solutions stocks are traded under the ticker EKGGF.
Is CardioComm Solutions stock price growing?▼
EKGGF stock has risen by +0% compared to the previous week, the month change is a -8.26% fall, over the last year CardioComm Solutions has showed a +150% increase.
What is CardioComm Solutions market cap?▼
Today CardioComm Solutions has the market capitalization of 1.98M
What were CardioComm Solutions earnings last quarter?▼
EKGGF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CardioComm Solutions revenue for the last year?▼
CardioComm Solutions revenue for the last year amounts to 194,826.29 USD.
What is CardioComm Solutions net income for the last year?▼
EKGGF net income for the last year is -383,658.04 USD.
How many employees does CardioComm Solutions have?▼
As of September 05, 2026, the company has 16 employees.
In which sector is CardioComm Solutions located?▼
CardioComm Solutions operates in the Health & Wellness sector.
When did CardioComm Solutions complete a stock split?▼
The last stock split for CardioComm Solutions was on November 28, 2007 with a ratio of 1:5.
Where is CardioComm Solutions headquartered?▼
CardioComm Solutions is headquartered in Toronto, Canada.